Alaunos Therapeutics (TCRT) FCF Margin Growth (1y) (2012 - 2025)
Alaunos Therapeutics (TCRT) FCF Margin Growth (1y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Alaunos Therapeutics |
4.31 Mn |
3.95 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-363,333.00 |
| Mar 31, 2025 |
15.31 Mn |
| Dec 31, 2024 |
72.37 Mn |
| Jun 30, 2024 |
13.64 Mn |
| Dec 31, 2023 |
-67.26 Mn |
| Dec 31, 2022 |
70.84 Mn |
| Sep 30, 2022 |
228,767.00 |
| Mar 31, 2018 |
-1.22 Mn |
| Dec 31, 2017 |
4,471.00 |
| Sep 30, 2017 |
9,587.00 |
| Jun 30, 2017 |
-7,959.00 |
| Mar 31, 2017 |
-9,182.00 |
| Dec 31, 2016 |
43,733.00 |
| Sep 30, 2016 |
-331,459.00 |
| Jun 30, 2016 |
340,700.00 |
| Mar 31, 2016 |
275,410.00 |
| Dec 31, 2015 |
164,244.00 |
| Sep 30, 2015 |
409,060.00 |
| Jun 30, 2015 |
-43,510.00 |
| Mar 31, 2015 |
74,932.00 |
